ATAD2 and hepatocellular carcinoma: Specifically, ATAD2 up-regulation was observed in 760 cancer samples of 14 different origins, compared to 112 normal somatic tissues [4], and this up-regulation was correlated with poor prognosis in lung cancer [4, 5], breast cancer [6], osteosarcoma [7], and HCC [8, 9].